enVVeno Medical
NVNO
3 hedge funds and large institutions have $244K invested in enVVeno Medical in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
18% less capital invested
Capital invested by funds: $298K → $244K (-$54K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$47K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $227K | +$2.9K | +2 | +1% |
|
|
2
UBS Group
Zurich,
Switzerland
| $10K | -$13K | -9 | -53% |
|
|
FIA
3
FNY Investment Advisers
New York
| $7K | – | – | – |
|
|
4
Jane Street
New York
| – | -$47K | -36 | Closed |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$20K | -16 | Closed |
|
NVNO Hedge Fund Activity: Q1 2019 in Review
3 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2019, worth a combined $244K — down 18% from $298K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NVNO and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Vanguard Group, adding an estimated $2.9K. The largest seller was Jane Street, exiting entirely with an estimated $47K sold.
- 3 institutional investors held enVVeno Medical (NVNO) as of Q1 2019, down from 5 in Q4 2018.
- Funds reported $244K of enVVeno Medical stock for Q1 2019, down 18% quarter-over-quarter.
- 0 funds opened new enVVeno Medical positions in Q1 2019 and 2 closed out, a net change of -2 holders.
- The largest enVVeno Medical buyer in Q1 2019 was Vanguard Group, an estimated $2.9K added.
- The largest enVVeno Medical seller in Q1 2019 was Jane Street, an estimated $47K sold.
Based on aggregated 13F filings for Q1 2019.